米技國際控股(01715.HK)與上海才楨訂立戰略合作框架協議
格隆匯5月23日丨米技國際控股(01715.HK)宣佈,於2022年5月23日,上海米眼波科技有限公司(公司間接全資附屬公司)與上海才楨科技有限公司("上海才楨")訂立戰略合作框架協議,內容有關銷售及分銷大健康行業相關產品("戰略合作框架協議")。
根據戰略合作框架協議,上海才楨將負責提供優質的大健康行業相關產品。集團將負責營銷及分銷上海才楨的大健康行業相關產品。集團將提供量身定製的營銷解決方案,亦將在其產品分銷網絡推出大健康行業相關產品。上海才楨與集團將於訂立正式合作協議前進行盡職審查。各訂約方將盡其合理努力協助另一方進行有關審查以使審查儘快完成。
據悉,上海才楨為一家於中國註冊成立的有限公司。其主要在中國從事提供醫療解決方案及供應醫療設備。
公司認為,中國消費者的健康意識正在迅速提升,中國對大健康行業相關產品的需求巨大。憑藉其營銷經驗及成熟的產品分銷網絡,公司認為,與上海才楨的戰略合作為業務增長的契機,亦可擴大及豐富公司的客户基礎。因此,董事會認為該戰略合作符合公司及其股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.